Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression
Kazuhisa Sugiu(Okayama University), Toshiyoshi Fujiwara(Okayama University)
Cited by 15
Related Papers
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
|JCI Insight|2018|148
Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma
|Oncotarget|2017|118
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|111